Craig-Hallum Initiates Coverage On Biodesix with Buy Rating, Announces Price Target of $3
Portfolio Pulse from Benzinga Newsdesk
Craig-Hallum initiates coverage on Biodesix (NASDAQ:BDSX) with a Buy rating and sets a price target of $3.
July 26, 2024 | 4:10 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Craig-Hallum has initiated coverage on Biodesix with a Buy rating and a price target of $3, indicating a positive outlook for the stock.
The initiation of coverage with a Buy rating and a specific price target of $3 by Craig-Hallum is likely to boost investor confidence in Biodesix, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100